Brett Budzinski

Brett Budzinski currently serves as Senior Vice President, General Counsel, Corporate and Governance, and Corporate Secretary at Alnylam Pharmaceuticals since November 2023. Prior experience includes roles such as Vice President, Deputy General Counsel at Mersana Therapeutics from April 2023 to August 2023, and Vice President, Corporate Legal at AstraZeneca from July 2021 to March 2023. Additionally, Brett held the position of Vice President, Mergers and Acquisitions, Legal at Alexion Pharmaceuticals, Inc. from December 2018 to July 2021, and served as Associate General Counsel at Takeda from November 2015 to December 2018. Earlier in the career, Brett was Counsel at WilmerHale for over a decade, from September 2003 to October 2015. Educational credentials include a Doctor of Law (JD) from Boston University School of Law (1999-2002) and a Bachelor of Arts (BA) in History from Princeton University (1993-1997).